Glaukos Corporation Share Price

Glaukos Corporation Share Price

NYSE: GKOS | Large Cap
$242.38
+$61.03 (33.65%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Glaukos Corporation Stock Performance

Open
$212.85
Prev. Close
$181.35
Circuit Range
N/A
Day Range
$207.96 - $243.67
Year Range
$76.91 - $243.67
Volume
3,77,369
Average Traded
$234.09

Glaukos Corporation Share Price Today

As of 30 October 2026, Glaukos Corporation's share price is $242.38. The stock opened at $212.85, compared to its previous close of $181.35. During today's trading session, Glaukos Corporation's share price traded between $207.96 and $243.67, with an average price of $225.81. Over the past 52 weeks, the stock has recorded a high of $243.67 and a low of $76.91. In terms of performance, Glaukos Corporation's share price has risen by 68.26% over the last six months and is up 175.31% on a year-on-year basis.

Glaukos Corporation Share Price Chart

Line chart of the Glaukos Corporation price trend over the selected period. The price rose overall, ranging from 208.19 to 243.67, ending at 241.70.
$207.96$243.67
L
Show Current Price
H

Glaukos Corporation Stock Fundamentals & Key Indicators

Market Cap
$13.86B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.19
Revenue (TTM)
$507.44B
Return On Equity (TTM)
-27.55%
Profit Margin
-36.99%
Debt to Equity
0.10
Quarterly Earnings Growth YoY
-13.25%

Glaukos Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$133.54$143.12$150.57$185.61
Net Profit-$16.23-$133.66-$19.78-$18.38
Net Profit Margin-12.15%-93.39%-13.14%-9.90%
Income ChangeN/A-723.54%85.20%7.08%

Glaukos Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$282.86$314.71$383.48$507.44
Net Profit-$99.20-$134.66-$146.37-$187.69
Net Profit Margin-35.07%-42.79%-38.17%-36.99%
Income ChangeN/A-35.75%-8.70%-28.23%

About Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Glaukos Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$162.25
$240.85
+46.65%
Sep 2026
$178.15
$164.24
-9.54%
Aug 2026
$169.56
$181.56
+8.80%
Jul 2026
$140.18
$166.87
+19.48%
Jun 2026
$102.76
$139.66
+35.19%
May 2026
$144.00
$103.31
-28.28%
Apr 2026
$109.00
$144.05
+33.67%
Mar 2026
$119.00
$107.77
-10.46%
Feb 2026
$119.81
$120.36
+0.78%
Jan 2026
$113.28
$119.43
+5.82%
Dec 2025
$105.67
$112.86
+6.18%
Nov 2025
$87.42
$106.29
+20.73%

GKOS Share Price FAQs